Literature DB >> 8033338

Thyroid hormone-induced alterations in phospholamban protein expression. Regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation.

E Kiss1, G Jakab, E G Kranias, I Edes.   

Abstract

The aim of the present study was to determine the changes in phospholamban protein levels and their regulatory effect on sarcoplasmic reticulum (SR) Ca2+ uptake and left ventricular function in hypothyroid and hyperthyroid rat hearts. Hypothyroidism was associated with decreases in basal left ventricular function (+dP/dt and -dP/dt), whereas in hyperthyroidism these parameters were elevated compared with values for euthyroid hearts. The maximal SR Ca2+ uptake rates were 12.8 +/- 1.1, 15.5 +/- 1.2, and 21.4 +/- 1.4 nmol Ca2+ per milligram per minute, and the EC50 values for Ca2+ were 0.76 +/- 0.09, 0.41 +/- 0.07, and 0.30 +/- 0.05 mumol/L assayed in homogenates from hypothyroid, euthyroid, and hyperthyroid hearts, respectively. The relative tissue level of phospholamban was increased (135%) in hypothyroidism and decreased (75%) in hyperthyroidism compared with euthyroidism (100%). An opposite trend was observed for the SR Ca(2+)-ATPase, which was depressed (74%) in hypothyroid hearts but increased (134%) in hyperthyroid hearts. Consequently, the relative ratio of phospholamban to Ca(2+)-ATPase was highest in hypothyroid and lowest in hyperthyroid hearts, and these changes correlated with changes in the EC50 of the SR Ca2+ uptake for Ca2+. Stimulation of hearts with 0.1 mumol/L isoproterenol revealed that the relaxant effects were lower in hyperthyroid hearts and higher in hypothyroid hearts compared with euthyroid hearts, consistent with the alterations in the phospholamban levels. The maximal increases in the speed of relaxation, elicited by isoproterenol stimulation, correlated with the changes in the relative ratio of phospholamban to Ca(2+)-ATPase in these hearts.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8033338     DOI: 10.1161/01.res.75.2.245

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  58 in total

1.  Heterologous expression of wild-type and mutant beta-cardiac myosin changes the contractile kinetics of cultured mouse myotubes.

Authors:  Gaynor Miller; Joanne Maycock; Ed White; Michelle Peckham; Sarah Calaghan
Journal:  J Physiol       Date:  2003-02-07       Impact factor: 5.182

2.  Repression of cardiac phospholamban gene expression is mediated by thyroid hormone receptor-{alpha}1 and involves targeted covalent histone modifications.

Authors:  Madesh Belakavadi; Jason Saunders; Noah Weisleder; Preethi S Raghava; Joseph D Fondell
Journal:  Endocrinology       Date:  2010-04-14       Impact factor: 4.736

3.  Tissue Doppler echocardiography in evaluation of cardiac effects of subclinical hypothyroidism.

Authors:  Huseyin Arinc; Huseyin Gunduz; Ali Tamer; Ergun Seyfeli; Mustafa Kanat; Hakan Ozhan; Ramazan Akdemir; Cihangir Uyan
Journal:  Int J Cardiovasc Imaging       Date:  2005-11-02       Impact factor: 2.357

4.  Thyroid hormone improves function and Ca2+ handling in pressure overload hypertrophy. Association with increased sarcoplasmic reticulum Ca2+-ATPase and alpha-myosin heavy chain in rat hearts.

Authors:  K C Chang; V M Figueredo; J H Schreur; K Kariya; M W Weiner; P C Simpson; S A Camacho
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

Review 5.  Cardiac β3 -adrenoceptors-A role in human pathophysiology?

Authors:  Ebru Arioglu-Inan; Gizem Kayki-Mutlu; Martin C Michel
Journal:  Br J Pharmacol       Date:  2019-04-22       Impact factor: 8.739

6.  Mechanisms of thyroid hormone control over sensitivity and maximal contractile responsiveness to beta-adrenergic agonists in atria.

Authors:  E K Seppet; A Kaasik; A Minajeva; K Paju; J J Ohisalo; R Vetter; U Braun
Journal:  Mol Cell Biochem       Date:  1998-07       Impact factor: 3.396

7.  Cardiac myosin heavy chain isoform exchange alters the phenotype of cTnT-related cardiomyopathies in mouse hearts.

Authors:  Ron Rice; Pia Guinto; Candice Dowell-Martino; Huamei He; Kirsten Hoyer; Maike Krenz; Jeffrey Robbins; Joanne S Ingwall; Jil C Tardiff
Journal:  J Mol Cell Cardiol       Date:  2009-12-31       Impact factor: 5.000

Review 8.  Signaling mechanisms in thyroid hormone-induced cardiac hypertrophy.

Authors:  Kaie Ojamaa
Journal:  Vascul Pharmacol       Date:  2009-12-11       Impact factor: 5.773

9.  Relation of Low T3 to One-Year Mortality in Non-ST-Elevation Acute Coronary Syndrome Patients.

Authors:  Selçuk Yazıcı; Tuncay Kırış; Ufuk S Ceylan; Sait Terzi; Aysun Erdem; Işıl Atasoy; Ayşe Emre; Kemal Yeşilçimen
Journal:  J Clin Lab Anal       Date:  2016-08-27       Impact factor: 2.352

10.  The correlation between left ventricular failure and right ventricular systolic dysfunction occurring in thyrotoxicosis.

Authors:  Ji Yeon Hong; Dae-Gyun Park; Jong Jin Yoo; Seung Min Lee; Min-Kwan Kim; Sung Eun Kim; Jun-Hee Lee; Kyoo-Rok Han; Dong-Jin Oh
Journal:  Korean Circ J       Date:  2010-06-29       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.